Chantelle L Ahlenstiel (Chantelle Ahlenstiel)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Rose Kitawi, Scott Ledger, Anthony D Kelleher, Chantelle L Ahlenstiel
Advances in HIV Gene Therapy. International journal of molecular sciences 25 (5) (2024)
Rose Kitawi, Scott Ledger, Anthony D Kelleher, Chantelle L Ahlenstiel
Advances in HIV Gene Therapy. International journal of molecular sciences 25 (5) (2024)
Rose Kitawi, Scott Ledger, Anthony D Kelleher, Chantelle L Ahlenstiel
Advances in HIV Gene Therapy. International journal of molecular sciences 25 (5) (2024)
Yuan Zhang, Juhura G Almazi, Hui Xin Ong, Matt D Johansen, Scott Ledger, Daniela Traini, Philip Michael Hansbro, Anthony D Kelleher, Chantelle L Ahlenstiel
Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract. International journal of molecular sciences 23 (5) (2022)
Esinam E Agbosu, Scott Ledger, Anthony D Kelleher, Jing Wen, Chantelle L Ahlenstiel
Targeted Nanocarrier Delivery of RNA Therapeutics to Control HIV Infection. Pharmaceutics 14 (7) (2022)
Catalina Méndez, Scott Ledger, Kathy Petoumenos, Chantelle L Ahlenstiel, Anthony D Kelleher
RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency. Retrovirology 15 (1) (2018)